We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Accurate, non-invasive, inexpensive blood test will help diagnose bowel cancer early (Photo courtesy of Swansea University)

Revolutionary Blood Test to Transform Early Diagnosis of Bowel Cancer

An accurate, non-invasive, inexpensive blood test can diagnose bowel cancer early and dramatically cut waiting times for diagnosis while reducing the need for unnecessary invasive procedures such as colonoscopies. More...
20 May 2022
Image: Mass spectrometry shown well-fit to detect key markers of Alzheimer’s (Photo courtesy of Pexels)

Mass Spectrometry Could Enable Early Prediction of Alzheimer’s Disease from Blood Samples

Research has confirmed that new mass spectrometry (MS)-based technologies can help better understand the pathogenesis of Alzheimer’s disease (AD), diagnose it at early stages, predict risks, and create more effective therapeutic approaches. More...
20 May 2022
Image: Molecular profiling of diseased joint tissue can predict response to arthritis treatment (Photo courtesy of QMUL)

Study Identifies Molecular Signatures in Arthritis Patients for Incorporation In Diagnostic Tests

New research has shown that molecular profiling of the diseased joint tissue can significantly impact whether specific drug treatments will work to treat rheumatoid arthritis (RA) patients. The incorporation of these molecular signatures in future diagnostic tests will be a necessary step to translate these findings into routine clinical care. More...
20 May 2022
Image: Biosensor technology could enable direct and sensitive analysis of clinical samples at POC (Photo courtesy of Unsplash)

Biosensor Technology Could Pave Way for POC Diagnosis of Cancer, Pathogens, and Other Diseases

Researchers have developed a biosensor using a method to generate nanostructured and nanoporous surfaces. This combined strategy not only provides the sensor with an unprecedented sensitivity but also makes it resistant to fouling by proteins. More...
19 May 2022
Image: Percepta Nasal Swab helps avoid unnecessary procedures, speeding time to diagnosis and appropriate treatment (Photo courtesy of Veracyte)

Nasal Swab Test Accurately Assesses Lung Cancer Risk Among Smokers with Lung Nodules

A nasal swab test has been shown to accurately assess lung cancer risk among current and former smokers with lung nodules, regardless of their smoking history burden and whether they are considered high risk for lung cancer. More...
19 May 2022
Image: therascreen EGFR Plus RGQ PCR Kit (Photo courtesy of QIAGEN)

Qiagen Launches RT qPCR Test for Sensitive Detection of EGFR Mutations to Guide NSCLC Treatment

QIAGEN N.V. (Venlo, Netherlands) has launched the therascreen EGFR Plus RGQ PCR Kit, a new in-vitro diagnostic test for sensitive EGFR mutation analysis that detects all currently known activating and resistance EGFR mutations and supports treatment decision making. More...
19 May 2022
Image: A minimally invasive diagnostic biomarker strategy has proven successful in detecting early esophageal cancer (Photo courtesy of Pexels)

Minimally Invasive Device Combined With Molecular Biomarkers Detects Early Esophageal Cancer

A novel, minimally invasive biomarker-based strategy has demonstrated a 90% success rate in detecting esophageal squamous cell carcinoma (ESCC) which comprises 80% of esophageal cancers globally. More...
19 May 2022
New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Collection and Transport System
PurSafe Plus®
ESR Analyzer
TEST1 2.0
8-Channel Pipette
SAPPHIRE 20–300 µL


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.